Shanghai Runda Med Tech Co - Asset Resilience Ratio

Latest as of June 2025: 0.42%

Shanghai Runda Med Tech Co (603108) has an Asset Resilience Ratio of 0.42% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shanghai Runda Med Tech Co (603108) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥57.80 Million

≈ $8.46 Million USD Cash + Short-term Investments

Total Assets

CN¥13.79 Billion

≈ $2.02 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2024)

This chart shows how Shanghai Runda Med Tech Co's Asset Resilience Ratio has changed over time. See Shanghai Runda Med Tech Co (603108) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Runda Med Tech Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai Runda Med Tech Co (603108) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥57.80 Million	0.42%
Total Liquid Assets	CN¥57.80 Million	0.42%

Asset Resilience Insights

Limited Liquidity: Shanghai Runda Med Tech Co maintains only 0.42% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shanghai Runda Med Tech Co Industry Peers by Asset Resilience Ratio

Compare Shanghai Runda Med Tech Co's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Agilent Technologies Inc NYSE:A	Diagnostics & Research	12.22%
Leveljump Healthcare Corp V:JUMP	Diagnostics & Research	32.45%
StageZero Life Sciences Ltd TO:SZLS	Diagnostics & Research	81.79%
RHYTHM Biosciences Ltd AU:RHY	Diagnostics & Research	2.74%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Integral Diagnostics Ltd AU:IDX	Diagnostics & Research	0.03%
Australian Clinical Labs Ltd AU:ACL	Diagnostics & Research	4.11%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%

Annual Asset Resilience Ratio for Shanghai Runda Med Tech Co (2017–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Runda Med Tech Co.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.57%	CN¥82.20 Million ≈ $12.03 Million	CN¥14.31 Billion ≈ $2.09 Billion	+0.17pp
2023-12-31	0.41%	CN¥58.00 Million ≈ $8.49 Million	CN¥14.31 Billion ≈ $2.09 Billion	-0.33pp
2022-12-31	0.73%	CN¥106.50 Million ≈ $15.58 Million	CN¥14.52 Billion ≈ $2.12 Billion	+0.52pp
2021-12-31	0.21%	CN¥25.49 Million ≈ $3.73 Million	CN¥12.02 Billion ≈ $1.76 Billion	-1.45pp
2020-12-31	1.67%	CN¥169.60 Million ≈ $24.82 Million	CN¥10.18 Billion ≈ $1.49 Billion	+0.34pp
2019-12-31	1.33%	CN¥120.00 Million ≈ $17.56 Million	CN¥9.03 Billion ≈ $1.32 Billion	-0.28pp
2017-12-31	1.61%	CN¥114.50 Million ≈ $16.75 Million	CN¥7.13 Billion ≈ $1.04 Billion	--

pp = percentage points

About Shanghai Runda Med Tech Co

SHG:603108 China Diagnostics & Research

Market Cap

$1.21 Billion

CN¥8.25 Billion CNY

Market Cap Rank

#8360 Global

#2156 in China

Share Price

CN¥13.67

Change (1 day)

+1.79%

52-Week Range

CN¥12.26 - CN¥20.04

All Time High

CN¥26.34